Y. Kuroki

发表

The Microtubule-binding Protein Hook3 Interacts with a Cytoplasmic Domain of Scavenger Receptor A*

H. Krämer, H. Sano, M. Ishino, 2007, Journal of Biological Chemistry.

Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases

R. Kretsinger, N. Tachi, Y. Kuroki, 2005, Cellular and Molecular Life Sciences CMLS.

A nested leucine rich repeat (LRR) domain: The precursor of LRRs is a ten or eleven residue motif

Y. Kuroki, N. Matsushima, Hiroki Miyashita, 2010, BMC Microbiology.

Autoantibody to alanyl‐tRNA synthetase in patients with idiopathic pulmonary fibrosis

M. Munakata, Toru Takahashi, Y. Ohtsuka, 2007, Respirology.

Pulmonary Surfactant Protein A Protects Lung Epithelium from Cytotoxicity of Human β-Defensin 3*

Motoko Takahashi, C. Nishitani, Y. Kuroki, 2012, The Journal of Biological Chemistry.

High performance liquid chromatographic separation of diacylglycerol acetates to quantitate disaturated species of lung phosphatidylcholine

Y. Kuroki, T. Akino, K. Itoh, 1985, Lipids.

This information is current as to Protect the Bladder from Infection Escherichia coli Adherence of Uropathogenic Surfactant Protein A Inhibits Growth and

Motoko Takahashi, R. Takamiya, N. Masumori, 2017 .

Surfactant Protein D Inhibits Adherence of Uropathogenic Escherichia coli to the Bladder Epithelial Cells and the Bacterium-induced Cytotoxicity

Motoko Takahashi, C. Nishitani, Y. Kuroki, 2012, The Journal of Biological Chemistry.

A novel type of binding specificity to phospholipids for rat mannose‐binding proteins isolated from serum and liver

H. Sano, Y. Kuroki, H. Chiba, 1997, FEBS letters.

Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.

Y. Kuroki, H. Takahashi, H. Q. Shen, 1996, American journal of respiratory cell and molecular biology.

In vivo role of aldehyde reductase.

T. Soga, N. Taniguchi, J. Fujii, 2012, Biochimica et biophysica acta.

Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells.

Y. Kuroki, J. Shannon, R. Mason, 1990, American journal of respiratory cell and molecular biology.

Novel leucine rich repeat domains in proteins from unicellular eukaryotes and bacteria.

Y. Kuroki, N. Matsushima, Hiroki Miyashita, 2014, Protein and peptide letters.

The Extracellular Toll-like Receptor 2 Domain Directly Binds Peptidoglycan Derived from Staphylococcus aureus *

H. Sano, H. Mitsuzawa, Y. Kuroki, 2002, The Journal of Biological Chemistry.

Interaction of Soluble Form of Recombinant Extracellular TLR4 Domain with MD-2 Enables Lipopolysaccharide Binding and Attenuates TLR4-Mediated Signaling1

K. Miyake, T. Himi, H. Sano, 2004, The Journal of Immunology.

Direct Binding of Toll-Like Receptor 2 to Zymosan, and Zymosan-Induced NF-κB Activation and TNF-α Secretion Are Down-Regulated by Lung Collectin Surfactant Protein A1

Toru Takahashi, H. Sano, Y. Kuroki, 2003, The Journal of Immunology.

Surfactant Protein A Down-Regulated by Lung Collectin Secretion Are α Activation and TNF-B κ Zymosan , and Zymosan-Induced NF-Direct Binding of Toll-Like Receptor 2 to

Toru Takahashi, H. Sano, Y. Kuroki, 2003 .

Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.

Toru Takahashi, H. Sano, Y. Kuroki, 2003, Journal of immunology.

Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis

Y. Kuroki, A. Watanabe, H. Chiba, 2014, BMC Pulmonary Medicine.

Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosis

G. Hunninghake, L. Newman, Y. Kuroki, 2002, European Respiratory Journal.

Horizontal gene transfer of plant-specific leucine-rich repeats between plants and bacteria

R. Kretsinger, Y. Kuroki, N. Matsushima, 2013 .

Analyses of non-leucine-rich repeat (non-LRR) regions intervening between LRRs in proteins.

Y. Kuroki, N. Matsushima, Hiroki Miyashita, 2009, Biochimica et biophysica acta.

Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis.

S. Abe, Y. Kuroki, H. Chiba, 2001, The European respiratory journal.

Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D

S. Abe, Y. Kuroki, H. Chiba, 2006, Respirology.

Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic values.

S. Abe, H. Sano, Y. Kuroki, 2002, Lung cancer.

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.

Hiroshi Tanaka, S. Abe, H. Tanaka, 2000, American journal of respiratory and critical care medicine.

Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients

R. Takamiya, Y. Kuroki, Y. Sakuma, 2017, Oncogene.

Characterization of the Ca2+-dependent binding of annexin IV to surfactant protein A.

D. Voelker, H. Sano, Y. Kuroki, 1999, The Biochemical journal.

[Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].

Y. Kuroki, K. Kida, N. Saita, 1995, Nihon Kyobu Shikkan Gakkai zasshi.

Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis.

S. Abe, S. Abe, Y. Kuroki, 1993, The American review of respiratory disease.

Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.

Y. Kuroki, N. Shijubo, H. Takahashi, 1993, Chest.

Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation

H. Xin, M. Maemondo, T. Nukiwa, 2008, Cancer science.

The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.

Motoko Takahashi, R. Takamiya, Y. Kuroki, 2014, Biochemical and biophysical research communications.

Pulmonary surfactant proteins.

D. Voelker, Y. Kuroki, 1994, The Journal of biological chemistry.

Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat.

D. Voelker, Y. Kuroki, J. Shannon, 1989, The American review of respiratory disease.

Binding specificity of lung surfactant protein SP-D for glucosylceramide.

Y. Kuroki, S. Gasa, M. Shiratori, 1992, Biochemical and biophysical research communications.

Development of an enzyme-linked immunosorbent assay for measurement of rat pulmonary surfactant protein D using monoclonal antibodies

Y. Kuroki, S. Kanazawa, M. Murata, 2010, Experimental lung research.

Attenuates TLR4-Mediated Signaling Enables Lipopolysaccharide Binding and Extracellular TLR4 Domain with MD-2 Interaction of Soluble Form of Recombinant

K. Miyake, T. Himi, H. Sano, 2004 .

Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D.

Y. Kuroki, E. Matsuura, S. Fujimoto, 1994, Journal of immunological methods.

Isolation and sequence of a cDNA clone for the rat pulmonary surfactant-associated protein (PSP-A).

K. Sano, D. Voelker, Y. Kuroki, 1987, Biochemical and biophysical research communications.

Pulmonary Inflammation in Mice and Dampen Lipopolysaccharide-Induced Lipopolysaccharide Binding on Cell Surface TLR4 Domain and MD-2 Inhibit Recombinant Soluble Forms of Extracellular

K. Fukase, H. Sano, Takeyuki Shimizu, 2006 .

Recombinant Soluble Forms of Extracellular TLR4 Domain and MD-2 Inhibit Lipopolysaccharide Binding on Cell Surface and Dampen Lipopolysaccharide-Induced Pulmonary Inflammation in Mice1

K. Fukase, H. Sano, Takeyuki Shimizu, 2006, The Journal of Immunology.

Diverse Functions of Pulmonary Collectins in Host Defense of the Lung

C. Nishitani, Y. Kuroki, S. Ariki, 2012, Journal of biomedicine & biotechnology.

Surfactant Proteins A and D Bind CD14 by Different Mechanisms*

D. Voelker, H. Sano, Y. Kuroki, 2000, The Journal of Biological Chemistry.

Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.

S. Nomura, D. Voelker, H. Sano, 1999, Journal of immunology.

This information is current as CD 14 Lipopolysaccharides by Interaction with the Cellular Response to Smooth and Rough Pulmonary Surfactant Protein A Modulates

S. Nomura, D. Voelker, H. Sano, 1999 .

Mannose-Binding Lectin Augments the Uptake of Lipid A, Staphylococcus aureus, and Escherichia coli by Kupffer Cells through Increased Cell Surface Expression of Scavenger Receptor A1

T. Kodama, Hiroshi Suzuki, K. Hirata, 2006, The Journal of Immunology.

Pulmonary Surfactant Protein A Augments the Phagocytosis of Streptococcus pneumoniae by Alveolar Macrophages through a Casein Kinase 2-dependent Increase of Cell Surface Localization of Scavenger Receptor A*

T. Kodama, Hiroshi Suzuki, S. Abe, 2004, Journal of Biological Chemistry.

Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid

Y. Nasuhara, K. Nagai, T. Betsuyaku, 2004, European Respiratory Journal.

Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.

S. Abe, S. Abe, Y. Kuroki, 1996, Chest.

Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.

S. Abe, S. Abe, Y. Kuroki, 1995, American journal of respiratory and critical care medicine.

Pulmonary surfactant protein D specifically binds to phosphatidylinositol.

Y. Kuroki, T. Akino, Y. Ogasawara, 1992, The Journal of biological chemistry.

Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma.

Y. Fukushima, T. Fukuda, Y. Kuroki, 2000, The European respiratory journal.

Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung.

H. Geuze, W. Voorhout, Y. Kuroki, 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Binding of annexins to lung lamellar bodies and the PMA-stimulated secretion of annexin V from alveolar type II cells.

H. Ohkawa, Y. Kuroki, H. Sohma, 2001, Journal of biochemistry.

Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells.

R. Pierce, Y. Kuroki, M. Orloff, 2010, Gastroenterology.

BAL Surfactant Protein A and Clara Cell 10-kDa Protein Levels in Healthy Subjects

T. Yamaguchi, S. Abe, Y. Kuroki, 1998, Lung.

Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2*♦

E. Chan, D. Voelker, H. Mitsuzawa, 2009, The Journal of Biological Chemistry.

Surfactant protein A (SP-A) and SP-A-derived peptide attenuate chemotaxis of mast cells induced by human β-defensin 3.

Motoko Takahashi, R. Takamiya, Y. Kuroki, 2017, Biochemical and biophysical research communications.

A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.

Y. Seto, K. Miyake, C. Nishitani, 2008, International immunology.

Pulmonary Collectins Play Distinct Roles in Host Defense against Mycobacterium avium

Motoko Takahashi, Takeyuki Shimizu, C. Nishitani, 2011, The Journal of Immunology.

Mycobacterium avium Host Defense against Pulmonary Collectins Play Distinct Roles in

Motoko Takahashi, Takeyuki Shimizu, C. Nishitani, 2011 .

Pulmonary Collectins Protect Macrophages against Pore-forming Activity of Legionella pneumophila and Suppress Its Intracellular Growth*

Motoko Takahashi, Takeyuki Shimizu, H. Mitsuzawa, 2010, The Journal of Biological Chemistry.

Surfactant Protein A Inhibits Peptidoglycan-induced Tumor Necrosis Factor-α Secretion in U937 Cells and Alveolar Macrophages by Direct Interaction with Toll-like Receptor 2*

D. Voelker, H. Sano, H. Mitsuzawa, 2001, The Journal of Biological Chemistry.

Surfactant proteins A and D: disease markers.

Y. Kuroki, H. Chiba, H. Takahashi, 1998, Biochimica et biophysica acta.

Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.

Y. Kuroki, R. Cherniack, R. Mason, 1990, The American review of respiratory disease.

Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid.

Y. Kuroki, S. Fujimoto, K. Hosoda, 1989, The Tohoku journal of experimental medicine.

Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases.

H. Sano, Y. Kuroki, H. Chiba, 2006, Current pharmaceutical design.

Regulation of inflammation and bacterial clearance by lung collectins

H. Sano, H. Mitsuzawa, Y. Kuroki, 2006, Respirology.

Mutational analysis of Cys(88) of Toll-like receptor 4 highlights the critical role of MD-2 in cell surface receptor expression.

Motoko Takahashi, Takeyuki Shimizu, H. Mitsuzawa, 2009, International immunology.

Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment.

Y. Kuroki, H. Shimizu, K. Miyamura, 1991, Biochimica et biophysica acta.

Pulmonary surfactant protein D binds MD-2 through the carbohydrate recognition domain.

Motoko Takahashi, Takeyuki Shimizu, H. Mitsuzawa, 2008, Biochemistry.

Differential lipid specificities of the repeated domains of annexin IV.

H. Ohkawa, Y. Kuroki, S. Gasa, 2001, Biochimica et biophysica acta.

Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine.

Y. Kuroki, T. Akino, Toyoaki Akino, 1991, The Journal of biological chemistry.

Alteration of annexin IV expression in alcoholics.

H. Ohkawa, Y. Kuroki, H. Sohma, 2001, Alcoholism, clinical and experimental research.

Increasing Antiviral Activity of Surfactant Protein D Trimers by Introducing Residues from Bovine Serum Collectins: Dissociation of Mannan‐Binding and Antiviral Activity

U. Holmskov, K. Hartshorn, Y. Kuroki, 2010, Scandinavian journal of immunology.

The 6-Fluoro-8-Methoxy Quinolone Gatifloxacin Down-Regulates Interleukin-8 Production in Prostate Cell Line PC-3

K. Shibata, H. Sano, Takeyuki Shimizu, 2006, Antimicrobial Agents and Chemotherapy.

Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection

H. Tsutsumi, H. Sano, Y. Kuroki, 2003, European journal of immunology.

The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain.

H. Sano, H. Mitsuzawa, C. Nishitani, 2005, Biochemical and biophysical research communications.

Ethanol-induced augmentation of annexin IV in cultured cells and the enhancement of cytotoxicity by overexpression of annexin IV by ethanol.

H. Ohkawa, Y. Kuroki, S. Murakami, 2002, Biochimica et biophysica acta.

Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease.

Y. Kuroki, T. Akino, K. Dempo, 1986, The American journal of pathology.

A 50-kDa variant form of human surfactant protein D.

L. D. Nielsen, J. Freed, Y. Kuroki, 1998, The European respiratory journal.

Implication of Antigenic Conversion of Helicobacter pylori Lipopolysaccharides That Involve Interaction with Surfactant Protein D

C. Nishitani, Y. Kuroki, S. Ariki, 2012, Infection and Immunity.

Mannose binding lectin and lung collectins interact with Toll-like receptor 4 and MD-2 by different mechanisms.

Motoko Takahashi, Takeyuki Shimizu, H. Mitsuzawa, 2009, Biochimica et biophysica acta.

Surfactant Protein A Directly Interacts with TLR4 and MD-2 and Regulates Inflammatory Cellular Response

T. Himi, H. Sano, Takeyuki Shimizu, 2006, Journal of Biological Chemistry.

Activity of Mannose Receptor through Increased Mycobacterium avium of Pulmonary Collectins Enhance Phagocytosis

S. Abe, D. Voelker, Y. Kumazawa, 2004 .

Improved Immunoassay for Determination of Surfactant (SP-A) in Human Amniotic the Protein A Fluid

Y. Kuroki, K. Hosoda, M. Hagisawa, 2006 .

Surfactant protein A amino acids Glu195 and Arg197 are essential for receptor binding, phospholipid aggregation, regulation of secretion, and the facilitated uptake of phospholipid by type II cells.

D. Voelker, Y. Kuroki, F. McCormack, 1994, The Journal of biological chemistry.

Epitope mapping for monoclonal antibody against human surfactant protein A (SP-A) that alters receptor binding of SP-A and the SP-A-dependent regulation of phospholipid secretion by alveolar type II cells.

Y. Kuroki, H. Sohma, T. Akino, 1995, Biochimica et biophysica acta.

Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells.

D. Voelker, Y. Kuroki, R. Mason, 1988, The Journal of biological chemistry.

Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.

S. Abe, Y. Kuroki, N. Shijubo, 1995, The European respiratory journal.

Lung s surfactant p protein-A a and c carcinoembryonic a antigen in p pleural e effusions d due tto llung a adenocarcinoma and m malignant m mesothelioma

S. Abe, Y. Kuroki, Hiroki Takahashi, 1995 .

Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay.

Y. Fukada, Y. Kuroki, H. Takahashi, 1985, Biochimica et biophysica acta.

Decreased Contents ofSurfactant Proteins AandDinBALFluids of Healthy Smokers

Y. Kuroki, Hiroki Takahashi, Y. Honda, 2015 .

[Surfactant protein A in bronchoalveolar lavage fluid from patients with idiopathic interstitial pneumonia].

S. Abe, Y. Kuroki, H. Takahashi, 1996, Nihon Kyobu Shikkan Gakkai zasshi.

Analysis of Chimeric Proteins Identifies the Regions in the Carbohydrate Recognition Domains of Rat Lung Collectins That Are Essential for Interactions with Phospholipids, Glycolipids, and Alveolar Type II Cells*

D. Voelker, H. Sano, Y. Kuroki, 1998, The Journal of Biological Chemistry.

Pre- and postnatal stimulation of pulmonary surfactant protein D by in vivo dexamethasone treatment of rats.

Y. Kuroki, H. Misaki, T. Akino, 1992, Life sciences.

A Study of the Binding of Immunoglobulin G and Immunoglobulin E from Children with Bronchial Asthma to Peptides Derived from Group II Antigen of Dermatophagoides pteronyssinus

Y. Sakiyama, S. Matsumoto, Y. Kuroki, 1993, Pediatric Research.

Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.

S. Abe, K. Kurokawa, Y. Kuroki, 2000, American journal of respiratory and critical care medicine.

Alloiococcus otitidis is a ligand for collectins and Toll‐like receptor 2, and its phagocytosis is enhanced by collectins

T. Himi, H. Sano, Takeyuki Shimizu, 2006, European journal of immunology.

Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide.

Tsuyoshi Saito, H. Sano, Takeyuki Shimizu, 2006, Biochemistry.

Peptidoglycansand Staphylococcus aureus Recognition of Diacylated Lipoproteins and Motif of Human Toll-Like Receptor 2 in the 107, 112, and 115 in a Leucine-Rich Repeat Involvement of Leucine Residues at Positions

K. Shibata, M. Yasuda, Y. Kuroki, 2013 .

Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6

Douglas T. Golenbock, Ken-ichiro Shibata, Akira Hasebe, 2004, Infection and Immunity.

Involvement of Leucine Residues at Positions 107, 112, and 115 in a Leucine-Rich Repeat Motif of Human Toll-Like Receptor 2 in the Recognition of Diacylated Lipoproteins and Lipopeptides and Staphylococcus aureus Peptidoglycans1

K. Shibata, M. Yasuda, Y. Kuroki, 2003, The Journal of Immunology.

Peptidoglycans Staphylococcus aureus Lipopeptides and Recognition of Diacylated Lipoproteins and Motif of Human Toll-Like Receptor 2 in the 107 , 112 , and 115 in a Leucine-Rich Repeat Involvement of Leucine Residues at Positions

K. Shibata, M. Yasuda, Y. Kuroki, 2003 .

Purification and characterization of bovine cone arrestin (cArr)

T. Maeda, Y. Kuroki, H. Ohguro, 2000, FEBS letters.

Core fucosylation of E‐cadherin enhances cell–cell adhesion in human colon carcinoma WiDr cells

J. Gu, D. Osumi, Y. Ikeda, 2009, Cancer science.

Characterization of pulmonary surfactant protein D: its copurification with lipids.

Y. Kuroki, M. Shiratori, T. Akino, 1991, Biochimica et biophysica acta.

Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins.

K. Ohtsubo, N. Taniguchi, Motoko Takahashi, 2009, Carbohydrate research.

Suppression of Heregulin β Signaling by the Single N-Glycan Deletion Mutant of Soluble ErbB3 Protein*

M. Tajiri, Y. Wada, Y. Ikeda, 2013, The Journal of Biological Chemistry.

Pulmonary collectins in innate immunity of the lung

Motoko Takahashi, C. Nishitani, Y. Kuroki, 2007, Cellular microbiology.

Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains.

Y. Kuroki, N. Matsushima, Shintaro Takatsuka, 2012, Gene.

Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors

Y. Kuroki, P. Enkhbayar, N. Matsushima, 2007, BMC Genomics.

Toll-like Receptor 4 Region Glu24–Lys47 Is a Site for MD-2 Binding

H. Sano, Takeyuki Shimizu, H. Mitsuzawa, 2006, Journal of Biological Chemistry.

Prostate cell lines secrete IL‐8 in response to mycoplasma hominis through Toll‐like receptor 2‐mediated mechanism

K. Shibata, H. Sano, Takeyuki Shimizu, 2006, The Prostate.

The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.

H. Sano, H. Mitsuzawa, C. Nishitani, 2005, Biochemical and biophysical research communications.

The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity.

Hitomi Sano, H. Sano, Y. Kuroki, 2005, Molecular immunology.

N-glycans of growth factor receptors: their role in receptor function and disease implications.

N. Taniguchi, Motoko Takahashi, Y. Kuroki, 2016, Clinical science.

Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling

M. Tajiri, R. Takamiya, C. Nishitani, 2014, Oncogene.

Low expression of alphaA-crystallins and rhodopsin kinase of photoreceptors in retinal dystrophy rat.

T. Maeda, Y. Kuroki, A. Maeda, 1999, Investigative ophthalmology & visual science.

Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.

J. Whitsett, K. Steinberg, T. Martin, 1999, American journal of respiratory and critical care medicine.

Pulmonary surfactant protein A: a serum marker of pulmonary fibrosis in patients with collagen vascular diseases.

S. Abe, Y. Kuroki, H. Takahashi, 1995, Clinica chimica acta; international journal of clinical chemistry.

Pulmonary Surfactant Proteins A and D Are Potent Endogenous Inhibitors of Lipid Peroxidation and Oxidative Cellular Injury*

Y. Kuroki, H. Davis, D. Hui, 2000, The Journal of Biological Chemistry.

Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.

K. Sano, K. Sugahara, K. Iyama, 1996, Laboratory investigation; a journal of technical methods and pathology.

Extracellular Toll-Like Receptor 2 Region Containing Ser40-Ile64 but Not Cys30-Ser39 Is Critical for the Recognition ofStaphylococcus aureus Peptidoglycan*

I. Wada, T. Himi, H. Sano, 2001, The Journal of Biological Chemistry.

Pulmonary alveolar proteinosis in infants

M. Satoh, H. Sano, Y. Kuroki, 1999, European Journal of Pediatrics.

Rat Mannose-Binding Protein A Binds CD14

Toru Takahashi, H. Sano, H. Mitsuzawa, 2001, Infection and Immunity.

Simplified monoclonal immunoassay for pulmonary surfactant 35-kDa apoprotein in human amniotic fluid.

H. Satoh, Y. Kuroki, S. Fujimoto, 1988, Clinical chemistry.

Disruption of the structural and functional features of surfactant protein A by acrolein in cigarette smoke

Y. Yamaguchi, Motoko Takahashi, R. Takamiya, 2017, Scientific Reports.

HIV‐1 Vpr induces TLR4/MyD88‐mediated IL‐6 production and reactivates viral production from latency

M. Shimura, C. Nishitani, Y. Kuroki, 2010, Journal of leukocyte biology.

Implication of Surfactant Apoprotein in Otitis Media with Effusion

Y. Kuroki, N. Yamanaka, A. Kataura, 1991, The Annals of otology, rhinology, and laryngology.

Two-Site “Simultaneous” Immunoassay with Monoclonal Antibodies for the Determination of Surfactant Apoproteins in Human Amniotic Fluid

Y. Fukada, Y. Kuroki, Hiroki Takahashi, 1985, Pediatric Research.

Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer‐associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome

Y. Nishimura, N. Sato, T. Maeda, 2001, European journal of immunology.

TLR4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide

Kazuro Furukawa, K. Ikeda, R. Taguchi, 2013, Proceedings of the National Academy of Sciences.

Pulmonary Collectins Enhance Phagocytosis of Mycobacterium avium through Increased Activity of Mannose Receptor1

S. Abe, D. Voelker, Y. Kumazawa, 2004, The Journal of Immunology.

Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.

Hiroki Takahashi, S. Abe, Y. Kuroki, 2005, Respiratory medicine.

Ontogeny of surfactant apoprotein D, SP-D, in the rat lung.

Y. Kuroki, M. Shiratori, T. Akino, 1991, Biochimica et biophysica acta.

Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion.

D. Voelker, Y. Kuroki, R. Mason, 1988, The Journal of biological chemistry.

Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A.

D. Voelker, Y. Kuroki, R. Mason, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D

Motoko Takahashi, R. Takamiya, Y. Kuroki, 2017, The Journal of Biological Chemistry.

Pulmonary surfactant protein a in pleural effusions

Y. Kuroki, N. Shijubo, M. Hirasawa, 1992, Cancer.

Lung adenocarcinoma with type II pneumocyte characteristics.

M. Satoh, Y. Kuroki, N. Shijubo, 1993, The European respiratory journal.

Pulmonary Surfactant Protein D Inhibits Lipopolysaccharide (LPS)-induced Inflammatory Cell Responses by Altering LPS Binding to Its Receptors*

Motoko Takahashi, D. Voelker, Takeyuki Shimizu, 2008, Journal of Biological Chemistry.

Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.

N. Sato, I. Wada, T. Maeda, 2000, Cancer research.

Mechanisms of photoreceptor cell death in cancer-associated retinopathy.

N. Sato, T. Maeda, H. Sahara, 2001, Investigative ophthalmology & visual science.

HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.

C. Nishitani, Y. Kuroki, M. Orloff, 2012, International immunology.

[Pulmonary surfactant proteins SP-A and SP-D].

Y. Kuroki, H. Takahashi, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Site-directed mutagenesis of surfactant protein A reveals dissociation of lipid aggregation and lipid uptake by alveolar type II cells.

D. Voelker, H. Sano, Y. Kuroki, 1998, Biochimica et biophysica acta.

Mutational Analysis of Arg197 of Rat Surfactant Protein A

D. Voelker, Y. Kuroki, F. McCormack, 1998, The Journal of Biological Chemistry.

Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.

N. Taniguchi, Yasuhiko Kizuka, S. Kitazume, 2015, Journal of proteomics.

Effects of aging on surfactant forms in rats.

K. Sugiyama, T. Fukuda, Y. Kuroki, 2000, The European respiratory journal.

Importance of the carboxy-terminal 25 amino acid residues of lung collectins in interactions with lipids and alveolar type II cells.

D. Voelker, H. Sano, Y. Kuroki, 2000, Biochemistry.

Introduction of mannose binding protein-type phosphatidylinositol recognition into pulmonary surfactant protein A.

D. Voelker, H. Sano, Y. Kuroki, 1999, Biochemistry.

Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids.

D. Voelker, Y. Kuroki, F. McCormack, 1994, The Journal of biological chemistry.

Calcium and dithiothreitol dependent conformational changes in beta-sheet structure of collagenase resistant fragment of human surfactant protein A.

Y. Kuroki, H. Sohma, T. Akino, 1993, Biochemistry and molecular biology international.

Interaction of phospholipid liposomes with plasma membrane isolated from alveolar type II cells: effect of pulmonary surfactant protein A.

Y. Kuroki, M. Shiratori, T. Akino, 1996, Biochimica et biophysica acta.

Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies.

M. Satoh, M. Mori, Y. Kuroki, 1987, Pathology, research and practice.

Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A.

Y. Kuroki, Y. Murata, M. Shiratori, 1991, The Biochemical journal.

Detection of N‐glycolyated gangliosides in non‐small‐cell lung cancer using GMR8 monoclonal antibody

Motoko Takahashi, T. Hasegawa, Y. Kuroki, 2013, Cancer science.

ASIC — LIVER , PANCREAS , AND BILIARY RACT epatitis C Virus Core Protein Subverts the Antiviral Activities of Human upffer Cells

R. Pierce, Y. Kuroki, J. Kurtis, 2022 .

Surfactant Protein A Inhibits Growth and Adherence of Uropathogenic Escherichia coli To Protect the Bladder from Infection

Motoko Takahashi, R. Takamiya, N. Masumori, 2017, The Journal of Immunology.

Pulmonary corpora amylacea contain surfactant apoprotein.

Y. Kuroki, T. Akino, M. Mizumoto, 1990, Pathology, research and practice.

Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signalling

M. Tajiri, R. Takamiya, C. Nishitani, 2015, Oncogene.

Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera.

S. Abe, Y. Kuroki, A. Nagata, 1997, Clinica chimica acta; international journal of clinical chemistry.

Functional Roles and Structural Analysis of Lung Collectins SP-A and SP-D

H. Sano, Y. Kuroki, 1999, Neonatology.

This information is current as Mycobacterium avium Host Defense against Pulmonary Collectins Play Distinct Roles in

Motoko Takahashi, Takeyuki Shimizu, C. Nishitani, 2011 .

Role of the C-terminal domain of pulmonary surfactant protein A in binding to alveolar type II cells and regulation of phospholipid secretion.

Y. Kuroki, Y. Murata, T. Akino, 1993, The Biochemical journal.

Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells.

Y. Kuroki, T. Akino, A. Tsuzuki, 1993, The American journal of physiology.

Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2*♦

E. Chan, D. Voelker, H. Mitsuzawa, 2009, The Journal of Biological Chemistry.

Purification and biochemical characterization of pulmonary surfactant protein A of horses.

Y. Kuroki, S. Hobo, T. Yoshihara, 1999, American journal of veterinary research.

Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.

S. Abe, Y. Kuroki, N. Shijubo, 1995, Respiration; international review of thoracic diseases.